Andrew Isaacs

Drew Isaacs is a highly accomplished and versatile leader with extensive experience in the Pharmaceutical, Consulting, and Medical Device sectors.

He holds an undergraduate degree in BioMedical Engineering from Boston University and dual MBA/MS degrees from Kean, along with a New Product Development certificate from Harvard Business School.

Drew has a strong track record in Global Strategic Planning, New Product Development, Marketing, Business Development, Change Management, and Technology Alliances.

His expertise spans from concept creation to product launch, encompassing areas like Medical Education, Brand Launches, Sales Team management, Consulting, and Technology Partnerships.

Known for his ability to drive bottom-line profitability, market share growth, and customer relationship excellence, Drew excels in generating insights, optimizing processes, and leading comprehensive go-to-market strategies.

His skill set includes New Product Development Assessments, Competitive Analysis, Brand Launches, Strategic Partnerships, and Global Commercial Strategy development across various therapeutic areas and organizations.

With a focus on Specialty Marketing, Sales Team Oversight, and Strategic Planning, Drew has delivered exceptional growth rates through targeted selling approaches, market research, and innovative sales training methods.

Drew's educational background includes certifications in Project Management, New Product Development, and Management Systems Analysis, acquired from reputable institutions like Harvard University, Kepner Tregoe, and Boston University.

Throughout his career, Drew has held key leadership roles at prominent companies such as Novartis, Bristol-Myers Squibb, Johnson & Johnson, and Cognizant, where he spearheaded Marketing Operations, Strategic Planning, Commercial Effectiveness, and Business Development initiatives.

His professional journey also includes positions like Chief Strategy Officer, General Manager, Vice President, and Program Director, reflecting his expertise in driving organizational growth, innovation, and strategic development in the Life Science industry.